p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)
Daniel F. Hayes(University of Michigan–Ann Arbor), Ann D. Thor(University of Colorado Anschutz Medical Campus), Matthew J. Ellis(University of California, Davis), Clifford A. Hudis(American Society of Clinical Oncology), Lori J. Goldstein(Shaanxi Research Association for Women and Family), Jonathan F. Lara, Eric P. Winer(University of Vermont), Donald A. Berry(Berry & Associates (United States)), I. Craig Henderson, James N. Ingle(Mayo Clinic), Susan M. Edgerton, Gloria Broadwater, Silvana Martino(Angeles Clinic and Research Institute), David P. Cowan(University of North Carolina at Chapel Hill), Ira J. Bleiweiss(Hospital of the University of Pennsylvania), Lynn G. Dressler(University of North Carolina at Chapel Hill), Larry Norton(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k